ABIVAX Declares the Composition of its Share Capital and Voting Rights

ABIVAX, listed on Euronext Paris, announced on June 19, 2025, the distribution of its share capital and associated voting rights as of May 31, 2025. The company, registered in Paris, has a capital of €634,542.05. A total of 63,454,205 shares are issued, equivalent to as many theoretical and exercisable voting rights, which reach 71,155,266. These figures include shares with voting restrictions and provide a complete view of regulatory thresholds. This transparency aims to properly inform the public and comply with the recommendations of the Autorité des Marchés Financiers (AMF).